The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


POULVAC IBMM + ARK Lyophilisate for suspension for spray administration for chickens



Zoetis Belgium S.A.VPA10387/053/001

Main Information

Trade NamePOULVAC IBMM + ARK Lyophilisate for suspension for spray administration for chickens
Active SubstancesAvian infectious bronchitis virus strain massachusetts 1263
Avian infectious bronchitis virus strain arkansas 3168
Dosage FormLyophilisate for suspension for spray administration
Licence HolderZoetis Belgium S.A.
License Holder Address2nd Floor, Building 10
Cherrywood Business Park, Loughlinstown
Co Dublin
Ireland
Licence NumberVPA10387/053/001

Group Information

ATC CodeQI01AD07 avian infectious bronchitis virus
Therapeutic ClassImmunological - Live Vaccine
SpeciesChickens

Status

License statusAuthorised
Licence Issued09/12/2013
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back